39 citations
,
January 1994 in “European Journal of Cancer” In this study, scalp hypothermia with the Theracool™ cooling machine was largely ineffective for preventing alopecia in breast cancer patients undergoing a chemotherapeutic regimen including cyclophosphamide and anthracyclines.
17 citations
,
June 2020 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” This paper provides an overview of scalp cooling as an effective and safe intervention for preventing chemotherapy-induced alopecia, addressing its impact on cancer patients and survivors.
13 citations
,
October 2021 in “Actas Dermo-Sifiliográficas” This review examines existing evidence on scalp cooling systems to prevent or reduce chemotherapy-induced hair loss in cancer patients, noting promising results and their increasing adoption in clinical practice.
The researchers in this study found that scalp cooling can reduce or prevent hair loss for about 50% of patients, depending on the type of chemotherapy used, and suggest that optimizing scalp cooling methods could further decrease hair loss incidence.
1 citations
,
June 2023 in “Sciential - McMaster Undergraduate Science Journal” This paper reviews scalp cooling as an effective method for preventing chemotherapy-induced alopecia, highlighting recent trials that demonstrate its ability to preserve and regrow hair, thus improving patient well-being.